Table 3.
Case No. | Age (y)/Sex | CD20 | CD3 | CD4 | CD8 | CD30 | CD43 | CD56 | ALK1 | TIA-1 | EMA | Ki67 | EBER |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 19/M | – | – | ND | ND | + | + | + | + | ND | + | 70% | – |
2 | 63/M | – | + | – | – | + | ND | + | – | + | – | 80% | – |
3 | 60/M | – | – | ND | ND | + | ND | + | + | + | ND | 70% | – |
4 | 52/F | – | + | + | + | + | + | + | – | + | ND | 90% | – |
5 | 13/F | – | – | + | – | + | + | + | + | ND | Few+ | 90% | – |
6 | 20/M | – | – | + | – | + | ND | + | + | + | + | 80% | – |
7 | 25/F | – | + | – | + | + | + | + | + | + | ND | 70% | – |
8 | 26/M | – | – | ND | ND | + | + | + | + | ND | + | 70% | – |
9 | 23/M | – | + | ND | ND | + | + | + | + | + | – | 50% | – |
10 | 35/M | – | – | ND | ND | + | + | + | + | + | + | 80% | – |
11 | 15/M | – | – | ND | ND | + | + | + | + | + | ND | 70% | – |
12 | 17/M | – | Few+ | + | – | + | + | + | + | + | – | 80% | – |
13 | 47/M | – | – | + | – | + | ND | + | – | ND | ND | 80% | – |
14 | 67/M | – | + | + | ND | + | + | + | – | – | – | 80% | – |
15 | 27/M | – | Few+ | – | + | + | + | + | + | + | Few+ | 80% | – |
16 | 8/F | – | – | ND | ND | + | – | + | + | ND | + | 50% | – |
17 | 19/F | – | – | ND | ND | + | + | + | + | + | + | 80% | – |
18 | 22/M | – | Few+ | ND | ND | + | + | + | – | + | – | 80% | – |
M male, F female, ND not done